Phase1, Pharmacovigilance Trainee

About your role

Phase1 is Orion’s paid trainee programme designed for university students, bringing together a large and diverse group of talents from various fields every year. In addition to interesting summer jobs with meaningful projects, the programme offers a variety of events, networking opportunities with other Phase1 Trainees and Orion employees, as well as small group mentoring to support your career! Could this be the first research phase of your Orion career? You can find more information about the Phase1 trainee programme on Orion’s website. 

We are looking for a Pharmacovigilance (PV) Trainee in Espoo for the summer 2026. In this Phase1 trainee position, you get to familiarize yourself with pharmacovigilance tasks through a comprehensive induction program. During the orientation, you will also become familiar with other tasks in the pharmacovigilance unit.

During this trainee period, you will be responsible for various tasks, such as receiving and handling of adverse reaction reports in PV database, translating them from Finnish to English, and assisting with other Pharmacovigilance Unit's tasks e.g. informing about PV agreements, archiving documentation, managing risk minimization materials and product information. 

This traineeship is planned to last about three months between 11 May and 31 August 2025.

What we offer

At Orion Pharma, you will gain broad exposure to the field of pharmacovigilance while taking on meaningful responsibilities throughout the summer. We offer you the chance to challenge yourself with diverse and interesting tasks. During your time with us, you will also develop a comprehensive understanding of Orion Pharma’s operations and the wide range of roles within our organization.

At Orion, your work creates true impact and well-being for our customers, patients and society at large. ​Our culture of friendliness, respect, mutual appreciation and diversity creates a safe working environment where you can strive for excellence. We offer a wealth of career paths and development opportunities that support the development of innovative solutions and improving the quality of life.

Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/.

Our expectations

• A suitable educational background for the role, such as being a 4th–5th year student in pharmacy or biomedicine.
• Proficiency in Finnish and good command of English, along with some familiarity with medical terminology.
• Strong IT skills and experience with information systems.
• Initiative, accuracy, and the ability to work effectively under strict deadlines.

Additionally, we value the ability to manage multiple ongoing tasks simultaneously and to contribute actively as a team member.

How to apply and additional information

Please apply as soon as possible, but no later than February 1st, 2026. We might start interviewing candidates during the application time, so please ensure that we have your application as soon as possible! For more details please contact Mila Harri 050-9664288 on Fri 9.1.2025 8-9 am or 3-5pm, Tues 13.1. at 4-5pm, Wed 14.1. at 9-10am, Wed 28.1. at 9-10am or 3-4pm.

Our Phase1 trainees will be paid a monthly salary of €2370–2625, depending on the number of completed study credits. In addition, the Phase1 trainees are eligible to various employee benefits offered by the company.

If you would like to know more about the application process and timelines, please visit our website. 
Welcome to build well-being with us next summer 2026!

Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person.

Unit description

Quality management (QM) is responsible for ensuring the quality of materials, products and operations, as well as maintaining and developing the quality system and monitoring the regulatory environment. Pharmacovigilance and Patient Safety unit is responsible for the global pharmacovigilance system of Orion Corporation and for the continuous safety surveillance, regulatory reporting and safety risk management activities of human and veterinary medicinal and non-medicinal products.

The QM function consists of about 350 experts who work in Quality Control, Quality Assurance, Quality System, Method Development and the Pharmacovigilance & Patient safety unit. We are located in Espoo, Turku, Salo and Kuopio plants, in addition to the Quality Assurance team in India reporting dotted-line to QM.

Orion Pharma Pharmacovigilance Unit is responsible for the safety monitoring and reporting of human and veterinary medicines that Orion Pharma markets, represents, or has under clinical development. In Finland, we have a total of about 35 people. Our PV Case Management team consists of around 12 dedicated professionals responsible for handling human and veterinary ICSR/AE reporting to regulatory authorities and licensed partners, along with a variety of related tasks.

#LI-DNI